CT/NG by GeneXpert at Dr. Essa Lab

Book at Dr. Essa Laboratories & Diagnostic Center · karachi

Book this test

Dr. Essa Laboratories & Diagnostic Center logo

Dr. Essa Laboratories & Diagnostic Center

30% off
Rs. 11,158Rs. 15,940

Introduction to CT/NG by GeneXpert at Dr. Essa Lab

The CT/NG by GeneXpert at Dr. Essa Lab is a state-of-the-art molecular diagnostic test designed for the rapid, highly sensitive, and specific detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). These two pathogens are the leading bacterial causes of sexually transmitted infections (STIs) globally. Left untreated, they can lead to severe reproductive health complications, including pelvic inflammatory disease (PID), ectopic pregnancy, tubal factor infertility, chronic pelvic pain, and neonatal transmission. Dr. Essa Lab, a trusted name in diagnostic services across Karachi and Pakistan, utilizes advanced Cepheid GeneXpert technology to deliver precise results, enabling timely clinical intervention and improved patient outcomes.

The GeneXpert system employs real-time Polymerase Chain Reaction (PCR) technology, which is a type of Nucleic Acid Amplification Test (NAAT). NAATs are widely recognized by global health authorities, including the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC), as the gold standard for diagnosing chlamydia and gonorrhea. Unlike traditional culture methods, which are slow and technically demanding, or antigen-detection assays, which lack sensitivity, the GeneXpert assay amplifies specific DNA sequences unique to Chlamydia trachomatis and Neisseria gonorrhoeae. This allows for the detection of even minute quantities of bacterial DNA, ensuring high diagnostic accuracy even in asymptomatic individuals.

This molecular assay is designed to evaluate various anatomical sites depending on clinical indications and patient presentation. It can be performed on male and female first-catch urine specimens, endocervical swabs, patient-collected or clinician-collected vaginal swabs, urethral swabs, and extragenital specimens such as pharyngeal and rectal swabs. By offering comprehensive testing across these diverse specimen types, Dr. Essa Lab ensures that clinicians can accurately identify infections localized to specific mucosal sites, which is critical for guiding targeted antimicrobial therapy and preventing the spread of infection.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is essential to ensure specimen quality and avoid false-negative or invalid results. Depending on the specimen type required for your CT/NG by GeneXpert test at Dr. Essa Lab, please follow these guidelines:

  • First-Catch Urine Specimens (Male and Female): The patient must not have urinated for at least one to two hours prior to specimen collection. The first 20 to 30 mL of the urine stream (the initial flow, not mid-stream) must be collected in a sterile, preservative-free collection cup. Collecting mid-stream urine may wash away the target bacterial DNA from the urethra, leading to inaccurate results.
  • Endocervical and Vaginal Swab Specimens: Female patients should avoid using vaginal douching, spermicides, contraceptive creams, or vaginal medications for at least 24 to 48 hours before the test. Testing should ideally not be performed during active menstruation, although moderate bleeding does not completely preclude testing if clinically urgent.
  • Urethral Swab Specimens (Male): If a urethral swab is clinically indicated, the patient should not have urinated for at least one hour prior to collection to ensure sufficient cellular material and bacterial load are present on the urethral mucosa.
  • Extragenital Swabs (Pharyngeal and Rectal): No specific dietary or fasting preparation is required. However, patients should avoid using antiseptic mouthwashes or rectal enemas immediately prior to the procedure.

During the Procedure

The specimen collection process is quick, safe, and designed to minimize patient discomfort. At Dr. Essa Lab, our trained clinical staff ensures the highest standards of hygiene and patient privacy during sample collection:

  • Urine Collection: The patient is provided with a sterile container and detailed instructions to collect the first-catch urine sample privately in the designated facility restroom. The sample is then transferred immediately to the laboratory transport medium.
  • Swab Collection: For clinician-collected endocervical or vaginal swabs, the patient lies comfortably on an examination table. A speculum is gently inserted, and a sterile swab is rotated against the mucosal surface to collect epithelial cells and secretions. For patient-collected vaginal swabs, clear instructions and a collection kit are provided to allow the patient to collect the sample privately.
  • Extragenital Swabs: For pharyngeal testing, a sterile swab is gently rubbed against the posterior pharynx and tonsillar areas. For rectal testing, a sterile swab is inserted approximately 2 to 3 cm into the anal canal and rotated against the rectal wall.
  • Laboratory Processing: Once collected, the specimen is placed into the GeneXpert vial containing transport reagent. The vial is loaded into the fully automated GeneXpert instrument. The system performs automated sample preparation, nucleic acid extraction, real-time PCR amplification, and target detection within a closed cartridge, minimizing the risk of cross-contamination and human error. The entire laboratory run takes approximately 90 minutes.

When is a CT/NG by GeneXpert Performed?

Screening for Asymptomatic Sexually Transmitted Infections

A significant challenge in controlling chlamydia and gonorrhea is that a vast majority of infected individuals remain completely asymptomatic. Up to 70-80% of women and 50% of men with these infections do not exhibit any clinical symptoms. Routine screening using the CT/NG by GeneXpert assay is highly recommended for sexually active young adults, individuals with new or multiple sexual partners, and those who do not consistently use barrier protection. Identifying and treating asymptomatic infections is crucial to breaking the chain of transmission and preventing long-term reproductive complications.

Evaluation of Pelvic Inflammatory Disease (PID) Symptoms

Physicians frequently request the CT/NG by GeneXpert test when a female patient presents with symptoms suggestive of Pelvic Inflammatory Disease (PID). These symptoms include lower abdominal pain, pelvic pain, abnormal or foul-smelling vaginal discharge, dyspareunia (painful intercourse), and post-coital bleeding. Because Chlamydia trachomatis and Neisseria gonorrhoeae are the primary etiological agents of PID, rapid molecular detection allows clinicians to initiate targeted antibiotic therapy promptly, reducing the risk of permanent scarring of the fallopian tubes.

Investigation of Male Urethritis and Epididymitis

In male patients, symptoms such as dysuria (pain or burning during urination), urethral discharge (which may be mucoid, purulent, or watery), testicular pain, and scrotal swelling warrant immediate diagnostic investigation. These symptoms are classic indicators of urethritis or epididymitis, often caused by CT or NG. The GeneXpert test provides rapid differentiation between these two pathogens, which is vital because the recommended antibiotic regimens for chlamydia and gonorrhea differ. Accurate diagnosis prevents the development of chronic epididymitis and potential fertility issues.

Prenatal Screening to Prevent Neonatal Transmission

Pregnant women are routinely screened for CT and NG during their prenatal visits, particularly during the first trimester and again in the third trimester if high-risk factors are present. Untreated maternal infections can lead to severe neonatal complications, including ophthalmia neonatorum (neonatal conjunctivitis), which can cause blindness, and neonatal pneumonia. Performing the CT/NG by GeneXpert test allows obstetricians to treat infected mothers prior to delivery, ensuring a safe vaginal birth and protecting the health of the newborn.

High-Risk Exposure and Partner Notification

When an individual is diagnosed with an STI, or if a person is notified that a sexual partner has tested positive for chlamydia or gonorrhea, immediate diagnostic testing is indicated. The CT/NG by GeneXpert test is performed to confirm whether transmission has occurred, even in the absence of symptoms. This targeted testing supports public health contact tracing efforts, ensures that all exposed partners receive appropriate medical management, and prevents the phenomenon of “ping-pong” reinfection between partners.

What Does a CT/NG by GeneXpert Detect?

The CT/NG by GeneXpert assay is designed to detect specific molecular targets and clinical parameters, including:

  • Presence of Chlamydia trachomatis genomic DNA.
  • Presence of Neisseria gonorrhoeae genomic DNA.
  • Active endocervical chlamydial infection.
  • Active endocervical gonococcal infection.
  • Male urethral chlamydial colonization.
  • Male urethral gonococcal colonization.
  • Asymptomatic pharyngeal gonococcal infection.
  • Asymptomatic pharyngeal chlamydial infection.
  • Asymptomatic rectal gonococcal infection.
  • Asymptomatic rectal chlamydial infection.
  • Co-infection with both Chlamydia trachomatis and Neisseria gonorrhoeae.
  • Specimen adequacy through internal sample processing controls.
  • Presence of PCR inhibitors in the sample (e.g., excess blood or mucus).
  • Successful nucleic acid extraction from the clinical specimen.
  • Efficacy of antibiotic treatment (when performed as a test-of-cure after an appropriate timeframe).
  • Potential source of pelvic inflammatory disease (PID) in symptomatic females.
  • Etiology of non-gonococcal urethritis (NGU) in males.
  • Etiology of acute epididymitis in young men.
  • Risk of neonatal transmission in pregnant patients.
  • Presence of bacterial DNA in cases of suspected ophthalmia neonatorum.
  • Asymptomatic carriage in high-risk populations.
  • Etiology of proctitis in patients presenting with rectal pain or discharge.
  • Etiology of severe pharyngitis following oral-genital exposure.
  • Confirmation of infection following a positive screening test from a less specific assay.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for diagnostic test results can be stressful, especially when dealing with infectious diseases. Because the GeneXpert system is a fully automated, cartridge-based platform, the laboratory processing time is highly efficient. Typically, results for the CT/NG by GeneXpert test are available within 24 to 48 hours of specimen collection. Dr. Essa Lab offers multiple convenient ways to access your diagnostic reports. Patients receive an automated SMS notification with a secure link as soon as the report is finalized by our consultant microbiologist. Reports can also be viewed, downloaded, and printed directly from the official Dr. Essa Lab website using the unique patient ID and password provided on the receipt. For those who prefer physical copies, reports can be collected from any of our conveniently located diagnostic centers across Karachi and other major cities.

CT/NG by GeneXpert Findings Overview

Structure / Parameter Evaluated Normal Findings Possible Abnormal Findings
Chlamydia trachomatis DNA Not Detected (Negative) Detected (Positive) indicating active infection
Neisseria gonorrhoeae DNA Not Detected (Negative) Detected (Positive) indicating active infection
Sample Processing Control (SPC) Passed (Valid Run) Failed (Invalid Run; requires recollection or retesting)
Endocervical Swab Quality Adequate cellular yield Inadequate cellular yield (poor collection technique)
First-Catch Urine Specimen No PCR inhibitors detected Inhibitors present (e.g., blood, vaginal lubricants, or crystals)
Pharyngeal Swab Specimen Not Detected (Negative) Detected (Positive) indicating pharyngeal colonization
Rectal Swab Specimen Not Detected (Negative) Detected (Positive) indicating rectal infection

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for CT/NG by GeneXpert?

  • Experienced Healthcare Professionals: Our molecular diagnostics department is supervised by highly qualified consultant pathologists and microbiologists.
  • Patient-Focused Care: We prioritize patient comfort, privacy, and confidentiality throughout the testing process.
  • Quality Diagnostic Services: Dr. Essa Lab maintains strict internal and external quality control protocols to ensure accurate results.
  • Professional Reporting: Clear, comprehensive, and easy-to-understand reports that facilitate prompt clinical decision-making.
  • Modern Diagnostic Approach: We utilize state-of-the-art Cepheid GeneXpert technology, the global standard for molecular STI detection.
  • Comfortable Environment: Our diagnostic centers are designed to provide a clean, hygienic, and welcoming experience for all patients.
  • Convenient Locations: With an extensive network of branches across Karachi, accessing diagnostic services is highly convenient.
  • Commitment to Accurate Diagnosis: We are dedicated to providing timely, evidence-based diagnostic insights to support your health journey.

Frequently Asked Questions